Half-time seminars Half-time review: Fredrik Sundquist
The use of somatostatin analogues and somatostatin receptor-based targeted radiotherapy to suppress re-growth and deplete metastatic disease in high-risk neuroblastoma.
Supervisor
Jakob Stenman, MD., Docent. Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Co-supervisor
Per Kogner, MD., Professor. Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Malin Wickström, Docent, Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Nikolas Herold, MD, Docent, Childhood Cancer Research Unit, Division of Pediatric Oncology and Surgery, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Half time committé
Daniel Bexell, MD, Docent. Molekylär barnonkologi, Avdelningen för translationell cancerforskning, Institutionen för laboratoriemedicin, Lunds Universitet
Trond Flaegstad, MD, Professor. Barneonkologi, Research group for Child and Adolescents Health, Tromsö Universitet
Katarzyna Fröss-Baron, MD, PhD. Institutionen för medicinska vetenskaper, Endokrin tumörbiologi, Uppsala Universitet